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ORIGINAL ARTICLE
The Effect of Adipose-Derived Stem Cell-Cultured 
Media on Oxazolone Treated Atopic Dermatitis-Like 
Murine Model
Hae-Jin Lee, M.D., Minyoung Jung, M.S., Jae-Hong Kim, M.D., Na Young Yoon, M.D., 
Eung Ho Choi, M.D., Ph.D.
Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea
Background: A stem cell is an undifferentiated cell that has 
the potential for self-renewal and differentiation. Adipose- 
derived stem cells (ADSCs) have advantages in accessibility 
and abundance compared to other kinds of stem cells and 
produce many growth factors and hormones. Objective: We 
investigated whether ADSC cultured media could be used as 
a therapy for atopic dermatitis. Methods: ADSC cultured 
media was topically applied twice daily for 5 days to 
oxazolone-treated atopic dermatitis-like hairless mice. 
Results: Topical application of ADSC cultured media im-
proved the epidermal permeability barrier and keratinocyte 
differentiation, and restored the predominant Th2 pheno-
type when compared to vehicle. ADSC cultured media- 
treated epidermis also showed an increase in the expression 
of antimicrobial peptides cathelin-related antimicrobial 
peptide, mouse beta-defensein 3. Conclusion: Topical 
ADSC cultured media could be useful in the treatment of 
atopic dermatitis. (Ann Dermatol 24(2) 181∼188, 2012)
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INTRODUCTION
Atopic dermatitis (AD) is a common, chronic inflammatory 
skin disorder characterized by pruritic skin lesions, immuno-
dysregulation, disrupted epidermal barrier function, and 
immunoglobulin E (IgE)-mediated sensitization to food and 
environmental allergens. The striking increase in the 
incidence of AD observed in recent decades has been 
attributed to the resettlement of populations from rural to 
urban areas, where a lack of early exposure to a variety of 
microbes purportedly results in reduced immune tole-
rance. Long-term systemic therapy or combinations of 
multiple treatments are often used in the management of 
AD. These conventional approaches for the treatment of 
AD include systemic and topical anti-inflammatory, anti- 
pruritic, and immunosuppressive agents, as well as photo-
therapy
1. However, no single agent is always effective for 
the treatment of AD. Therefore, many studies have sought 
to develop novel agents or methods for the management 
of AD.
The stem cell is an undifferentiated cell that has the 
potential for self-renewal and differentiation. Recently, 
adult stem cells have received attention because they are 
associated with fewer ethical difficulties than embryonic 
stem cells and less potential risk of carcinogenesis. Among 
adult stem cells, adipose-derived stem cells (ADSCs), 
mesenchymal stem cells that are extracted from human 
adipose tissue, have essentially the same properties as 
stem cells derived from bone marrow
2. Moreover, ADSC 
have relative advantages in accessibility and abundance 
compared to other types of adult stem cells and produce 
many growth factors and hormones. Recently, several 
studies of the mechanism of action of stem cells such as 
anti-inflammatory and immunomodulatory actions have HJ Lee, et al
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Fig. 1. Methods of multiple oxazolone (Ox) challenges and 
topical administration of adipose-derived stem cell cultured 
media.
been reported
3-5. Therefore, we investigated whether ADSC 
cultured media could be used as a novel therapeutic 
modality for AD.
As a model of AD, an epidermal hyperproliferative model 
(ideally also accompanied by dermal inflammation) would 
be preferred to assess the therapeutic efficacy and to study 
the action mechanisms responsible for the efficacy of 
ADSC cultured media. Therefore, this study employed an 
oxazolone-induced AD-like mouse model
6 to assess the 
therapeutic efficacy of topical ADSC cultured media.
MATERIALS AND METHODS
Animals and materials 
Twenty five female hairless mice (8 weeks old) were 
purchased from the animal laboratory of Yonsei Uni-
versity. Mice were kept under controlled humidity (40%) 
and temperature (22±2
oC). 4-Ethoxymethylene-2-phenyl- 
2-oxazolin-5-one (oxazolone) and acetone were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). All laboratory 
measurements were performed under blinded conditions 
or by blinded researchers. Study sample sizes were deter-
mined based on available reference data for epidermal 
permeability barriers
7.
Development and treatment of hapten-induced der-
matitis with features of AD in mice
All animal procedures were approved by the Yonsei Uni-
versity Wonju Campus Institutional Animal Care and Use 
Committee. Development of a hapten (oxazolone)-induced, 
murine model with multiple features of AD (oxazolone- 
AD) was described in previous studies
6. Each group (n=6 
for each) of mice was sensitized by one topical treatment 
with 60 μl of 5% oxazolone, while the ethanol-treated 
vehicle group (n=6) served as the control (Fig. 1). After 13 
days of multiple oxazolone challenges, all mice were 
evaluated the basal transepidermal water loss (TEWL), 
stratum corneum hydration and severity of erythema, and 
there is no statistical differences between each groups 
except the ethanol-treated vehicle group (data not shown).
Preparation of ADSC from adipose tissue and human 
fibroblasts
Subcutaneous adipose tissue was obtained from healthy 
female human donors and washed three times with 
phosphate buffered saline (PBS) to remove debris and red 
blood cells. Washed aspirates were digested with 0.075% 
collagenase (Type 1; Sigma-Aldrich) for 45 min at 37
oC 
with constant shaking. Mature adipocytes and connective 
tissues were separated from the pellets by centrifugation at 
1,200 rpm for 10 min. Pellets were resuspended in PBS, 
passed through a 100 μm mesh filter, and washed twice 
with PBS. The cell pellets containing ADSC were 
resuspended in low glucose Dulbecco’s modified Eagle’s 
medium (DMEM; Gibco, Grand Island, NY, USA) supple-
mented with 10% fetal bovine serum  (Gibco) and 100 
U/ml penicillin and 100 μg/ml streptomycin (Gibco), and 
plated at a density of 2∼3×10
5 cells/cm
2 in T75 flasks. 
Cultures were maintained at 37
oC in a humidified 
atmosphere containing 5% CO2. After 7∼10 days, the 
cells were detached and remnant extract (media without 
cells) was used as ADSC cultured media. 
Human dermal fibroblastic MRC-5 cells were obtained 
from American Type Culture Collection (No. CCL-171; 
Manassas, VA, USA) and used as controls, and cultured in 
the aforementioned supplemented DMEM. 
Evaluation of the effects of ADSC cultured media 
After sensitization by oxazolone, 30 μl of ADSC cultured 
media were topically applied twice a daily with a 
micropipette on the dorsal skin ADSC cultured media 
applied (AM) group of each mouse for 10 days. For the 
control groups, minimal media applied (MM) group, 
fibroblast cultured media applied (FM) group and gluco-
corticosteroid (0.1% methylprednisolone aceponate cream, 
S) were topically applied (0.2 g twice daily). Twenty four 
hours after the last treatment, biopsy specimens were 
taken to evaluate changes in morphology and protein 
expression. 
Both at baseline and at the end of the treatment period, 
basal TEWL was measured with a Tewameter TM210 
electrolytic water analyzer (Courage and Khazaka, Cologne, 
Germany) and was stratum corneum (SC) hydration assessed 
as capacitance with a Corneometer CM820 (Courage and 
Khazaka) was measured immediately before each appli-
cation of oxazolone and at 24 hours after the final 
application of oxazolone as described previously
8.
Tissue preparation, immunohistochemistry, and immuno-
fluorescence
Terminal differentiation marker proteins of keratinocytes 
(filaggrin, involucrin, and loricrin; Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) were used for immune identifi-ADSC Media on Atopic Dermatitis Model
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cation of epidermal differentiation. Briefly, 5 μm-thick 
paraffin sections were incubated with primary antibody 
overnight at 4
oC. After three washes, sections were incu-
bated with the secondary antibody for 30 min. Staining 
was detected with an ABC-peroxidase kit (Vector Lab, 
Burlingame, CA, USA), and sections were then counter-
stained with hematoxylin. To assess the immunohisto-
chemistry of proliferating cells, changes in overall mor-
phology were visualized after hematoxylin and eosin 
staining of 5 μm-thick paraffin-enabled sections, and pro-
liferating cells were detected by proliferating cell nuclear 
antigen staining.
Immunofluorescence was used to evaluate changes in T 
helper 2 cell subpopulation expression. Five micrometer- 
thick frozen sections were incubated with rabbit anti- 
mouse Th2 immunophenotype (CRTH2)/DP2 antibody 
overnight at 4
oC, followed by incubation with fluore-
scence conjugated goat anti- rabbit antibody for 30 min at 
room temperature. Both cathelin-related antimicrobial 
peptide C (CRAMP) (murine homolog of LL37) and mouse 
beta-detensin 3 mouse beta-defensin (mBD3) (murine 
homolog of human β-defensin 2) protein levels were 
assessed to determine whether antimicrobial peptide (AMP) 
expression changes were present in the epidermis, as 
described for human AD
9. Slides were counterstained 
with propidium iodide and visualized on a TCS-SPE 
confocal microscope (Leica Systems GmbH, Watzlar, 
Germany) Controls without primary antibody showed no 
immunolabeling
10.
To quantify the density of markers, three pictures for each 
section were taken at a 100x magnification and were 
labeled. An investigator without knowledge of the origin 
of the specimen ranked the pictures in order of the 
intensity of immunostaining (highest intensity: first rank, in 
descending order in each). Mann-Whitney test was used 
for statistics. A representative picture for each group was 
chosen for publication.
Western blot 
Murine dermal samples were homogenized in mammalian 
cell lysis buffer from a Qproteome Mammalian Protein 
Prep Kit (Qiagen, Valencia, CA, USA) containing Benzonase
Ⓡ 
(Merck, Darmstadt, Germany) nuclease and protease 
inhibitor solution. Lysates were centrifuged at 14,000 g for 
10 min, and supernatants were collected to perform 
Western blots. Protein concentration was determined by a 
Bradford assay. Equal amounts of proteins were resolved 
by 10% SDS-polyacrylamide gel electrophoresis and 
electrophoretically transferred to polyvinylidene difluoride 
membranes. Membranes were subsequently blocked with 
5% skim milk in TBST (20 mM Tris-HCl, pH 7.6, 137 mM 
NaCl, 0.1% Tween-20) and incubated with the indicated 
antibodies. For detection of CRAMP and mBD3, CRAMP 
antibody and mBD3 antibody were purchased from Santa 
Cruz Biotechnology. Blotting proteins were visualized by 
enhanced chemiluminescence (Amersham, Buckingham-
shire, UK).
Quantitative real-time reverse transcriptase-polymerase 
chain reaction (RT-PCR)
Total RNA was isolated from skin specimens using Trizol, 
then resuspended in RNase-free water and quantified with 
an ultraviolet spectrophotometer (Perkin Elmer, Waltham, 
MA, USA). Single-strand cDNA was prepared from 1 μg 
of total RNA in a 20 μl reaction volume using an Oligo- 
dT primer (Roche Molecular Systems, Branchburg, NJ, 
USA), which contained 5 mM MgCl2, 1 mM dNTP 
mixture, 1 U/μl RNase inhibitor (Roche Molecular Systems) 
and 0.25 U/μl M-MLV reverse transcriptase (Promega, 
Madison, WI, USA).
Real-time RT-PCR was performed on a Rotor-Gene
TM 3000 
(Corbett Life Science, NSW, Australia) using SYBR Green 
PCR Master Mix (Qiagen). All primers and probes were 
from Operon Biotechnologies (Huntsville, AL, USA). Primer 
and probe sequences for real-time RT-PCR analyses were: 
FAS primers (forward: 5’-CTGAAGAGCCTGGAAGATCG-3’, 
reverse: 5’-TGTCACGT TGCC ATG G TACT-3’) and FAS 
probe (5’-TGAGCTTTGCTG CCGTGTCC-3’); SPT primer 
(forward: 5’-GAGAGATGCTGAAGCGGAAC-3’, reverse: 
5’-TGGTATGAGCTGCTGACAGG-3’) and SPT probe (5’- 
TGGGATTTCCTGCTACCCCG-3’). CRAMP and mBD-3 PCR 
products were quantitatively analyzed with densitometry 
and then normalized to β-actin.
Statistical analysis
Paired t-tests were used for statistical analysis of the 
results, with p＜0.05 considered to be statistically 
significant.
RESULTS
Topical ADSC cultured media restores the epidermal 
permeability barrier impaired by multiple oxazolone 
challenge
We evaluated the effect of ADSC cultured media on the 
epidermal permeability barrier that had been disrupted by 
multiple oxazolone challenges. Basal TEWL was increased 
by oxazolone challenge compared with vehicle (C group) 
(Fig. 2A). But, after topical application of AM group (p
＜0.001) and steroids applied (S) group, p＜0.005) TEWL 
was significantly lower than other treatments (FM and MM 
group). Furthermore, topical application of AM group, FM HJ Lee, et al
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Fig. 2. (A) Basal TEWL (gm
−2h
−1) was checked after the fifth challenge of oxazolone (MM-pre, AM-pre, FM-pre, S-pre). The AM 
group and S group showed significant decreases in TEWL after treatment (C-post, MM-post, AM-post, FM-post and S-post). (B) SC 
hydration after treatment. AM, FM, and S groups showed significant improvement of SC hydration. Data are expressed as mean±standard 
deviation; n=6 in MM, AM, and FM group; n=4 in C group; n=3 in S group. TEWL: transepidermal water loss, SC: stratum corneum, 
C: control group, MM: minimal media applied group, AM: adipose-derived stem cell cultured media applied group, FM: fibroblast 
cultured media applied group, S: steroid applied group.
Fig. 3. Gross lesions of pre- and post-treatment with media in
the atopic dermatitis model. The AM group and S group showed
an improvement in skin lesions grossly. C: control group, MM:
minimal media applied group, AM: adipose-derived stem cell
cultured media applied group, FM: fibroblast cultured media 
applied group, S: steroid applied group.
group, and S group improved the hydration of the stratum 
corneum compared with the MM group (Fig. 2B). Topical 
application of ADSC cultured media also improved visible 
lesions (Fig. 3). Skin that was treated with ADSC extracts 
in the absence of multiple oxazolone challenges showed 
no changes in barrier function (data not shown).
Topical ADSC cultured media reverses the predomi-
nant Th2 phenotype and increases keratinocyte 
differentiation
We next determined whether the oxazolone-induced 
murine model of AD displayed the Th2 dominant 
immunophenotype and whether abnormal keratinocyte 
differentiation was reversed. After repeated oxazolone 
challenges, lymphocyte-dominant infiltrates increased pro-
gressively with some lymphocytes appearing to invade the 
overlying epidermis. Most became CRTH2-positive, indi-
cating a Th2 phenotype. Epidermal manifestations of 
filaggrin, loricrin, and involucrin, which represent the 
differentiation marker proteins of keratinocytes, decreased. 
In the AD-like model, topical application of ADSC cultured 
media resulted in a significant decrease in CRTH2 
immunostaining, representing Th2 lymphocytes, and also 
resulted in a significant increase in the markers for 
keratinocyte differentiation (Fig. 4) compared with the 
MM and FM groups (p＜0.05). In addition, there are no 
significant changes of keratinocyte differentiation that was 
treated with ADSC extracts in the absence of oxazolone 
challenges (data not shown).
Topical ADSC cultured media reverses the expression 
of AMP at both the mRNA and protein levels, which is 
reduced in the AD model
The epidermal permeability barrier and AMP expression 
are co-regulated and have interrelated functions. We, 
therefore, assessed whether topical ADSC extracts reversed ADSC Media on Atopic Dermatitis Model
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Fig. 4. Th2 immunophenotype (CRTH2) and keratinocyte differentiation (filaggrin, involucrin, and loricrin) after treatment. Immuno-
histochemical staining was carried out with diaminobenzidine and primary antibodies as indicated. Merged images with propidium
iodide secondary staining in 5 mm-thick frozen sections. C: control group, MM: minimal media applied group, AM: adipose-derived
stem cell cultured media applied group, FM: fibroblast cultured media applied group, S: steroid applied group (Mag bars=2 mm).
Fig. 5. Topical application of adipose-derived stem cell cultured media enhanced the epidermal expression of antimicrobial peptides
such as mBD3 and CRAMP. Immunohistochemical staining was carried out with diaminobenzidine and primary antibodies as indicated.
mBD3: mouse beta-defensin 3, CRAMP: cathelin-related antimicrobial peptide, C: control group, MM: minimal media applied group,
AM: adipose-derived stem cell cultured media applied group, FM: fibroblast cultured media applied group, S: steroid applied group
(Mag bars=2 mm).
AMP expression, which was reduced by multiple oxa-
zolone challenges. Immunohistochemical staining for mBD3 
and immunofluorescent staining for CRAMP were carried 
out with the same mouse skin samples. There are no 
significant changes of AMP expressions that were treated 
with ADSC extracts in the absence of oxazolone challenges 
(data not shown). However, topical application of ADSC 
cultured media induced increased epidermal expression 
of AMP compared with other treatments (MM and FM 
groups) in the murine model of AD (Fig. 5). Immuno-
histochemical staining was confirmed by Western blot 
analysis, which showed that protein levels of mBD3 and 
CRAMP significantly increased after topical application of 
ADSC cultured media (Fig. 6A, p＜0.05). The mRNA 
levels of mBD3 and CRAMP were quantified at the trans-
criptional level by real-time RT-PCR (Fig. 6B), and were 
significantly higher in the AM and S groups than in other 
treatment groups (MM and FM, p＜0.05).
DISCUSSION
This study aimed to investigate the potential of ADSC 
cultured media to restore the epidermal permeability 
barrier and AMP expression, both of which were dis-HJ Lee, et al
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Fig. 6. Topical application of adipose-derived stem cell cultured media increased the protein and mRNA levels of mBD3 and CRAMP 
compared with other treatments in Western blots (A) and for mRNA of mBD3 and CRAMP compared with vehicle in real-time reverse 
transcriptase-polymerase chain reaction (B). This is compatible with immunohistochemical staining results. Data are expressed as 
mean±standard deviation; n=6 in MM, AM and FM group; n=4 in C group; n=3 in S group. CRAMP: cathelin-related antimicrobial 
peptide; mBD3: mouse beta-defensin 3, C: control group, MM: minimal media applied group, AM: adipose-derived stem cell cultured 
media applied group, FM: fibroblast cultured media applied group, S: steroid applied group.
rupted by multiple oxazolone challenges in an animal 
model of AD. Based on our results, we believe that topical 
ADSC cultured media can reduce the features of AD. 
Stem cell therapy is becoming accepted as a new para-
digm for the repair of organ function after damage by 
disease or trauma
11. Embryonic stem cells obtained from 
human fetuses have been investigated, but barriers 
encountered include ethical concerns and potential for 
carcinogenesis. Adult stem cells are different from embry-
onic stem cells because they are obtained after the 
developmental process is completed and can be harvested 
after birth. In addition, adult stem cells have variable 
reproductive properties and potentials, which are like the 
characteristics of embryonic stem cells. Furthermore, adult 
stem cells have the possibility of self-transplantation
12. 
Mesenchymal stem cells, a subtype of undifferentiated 
adult stem cells, are present in differentiated tissues or 
organs. Among mesenchymal stem cells, ADSC have the 
relative advantages of accessibility and abundance. They 
are easily obtained from subcutaneous fat tissue with little 
pain to the patient. In addition, the possibility of an 
immunologic reaction is reduced because the cells 
originate from autologous stem cells. For these reasons, 
many recent experiments on stem cells have used ADSC. 
Here, we applied the cultured media of ADSC because it 
contains many proteins and cytokines released from 
ADSC.
In AD, decreased SC hydration leads to a steeper water 
gradient across the SC as a result of filaggrin deficiency, 
thereby ‘driving’ increased transcutaneous water loss. In 
addition, decreased generation of filaggrin products results 
in an initial increase in the SC pH, which can precipitate 
multiple downstream structural and functional alterations, 
including Th2 inflammation and degrading AMPs. Kerati-
nocyte differentiation is also incomplete in AD lesions
13. 
In the oxazolone-induced murine model of AD, perme-
ability barrier function and expression of differentiation 
proteins like filaggrin, loricrin, and involucrin became 
abnormal. A CRTH-positive, Th2-dominant inflammatory 
infiltrate with increased IL-4 expression and a large 
increase in serum IgE levels were observed. Moreover, 
CRAMP and mBD3, as well as SC ceramide, declined after 
oxazolone challenges, paralleling the decrease of their 
human homologues in AD
6. Therefore, we used an 
oxazolone-induced murine model of AD in this study to 
investigate the restoration of overall barrier function in ADSC Media on Atopic Dermatitis Model
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AD.
In this study, we compared treatment with ADSC media to 
other treatments in order to determine whether ADSC 
media improves visible AD lesions, TEWL, SC hydration, 
and abnormal keratinocyte differentiation in an oxazolone- 
induced animal model. In our murine model of AD, the 
decreased overall skin barrier function and differentiation 
markers, involucrin, filaggrin, and loricrin, were improved 
after application of ADSC extracts compared with the 
vehicle-treated group. These findings suggest that topical 
ADSC cultured media has a barrier recovery function 
when applied to the skin lesions of AD.
Recently, some studies have reported on the anti-inflamma-
tory effects of mesenchymal stem cells, which produce 
pro-inflammatory cytokines like transforming growth factor- 
beta (TGF-β), hepatocyte growth factor (HGF), interleukin 
(IL)-4, IL-10, and prostaglandins, or some combination 
thereof, and suppress the cytokines/chemokines involved 
in activation, differentiation, and recruitment of immuno- 
regulatory cells such as neutrophils, basophils, B cells, T 
cells, granulocytes, and cells noted for exacerbating 
inflammation such as monocytes/macrophages
3,4. In our 
study, we confirmed that cultured media of ADSC has an 
anti-inflammatory effect on an oxazolone induced murine 
model of AD compared with other treatments, including 
control media. Therefore, we believe that ADSC cultured 
media contains anti-inflammatory cytokines and/or 
chemokines released from ADSC, and that these products 
are a mechanism for relieving inflammation and restoring 
Th2 dominant lymphocytes in the dermis.
AMPs contribute to the establishment of adaptive immune 
reactions and inflammation and also play a major role in 
innate immunity to defend against microbes
14. Although 
decreased expression of AMP is related to increased 
susceptibility to cutaneous infections in atopic skin, 
excessive and uncontrolled expression of AMP may be 
involved in the induction and propagation of inflamma-
tion in psoriatic skin
14. Thus, as dysregulated expression of 
AMP may be important for the pathogenesis of various 
chronic inflammatory diseases, controlling and balancing 
AMP expression may offer a novel therapeutic approach
15. 
Human mesenchymal stem cells have direct antimicrobial 
activity, which is mediated in part by the secretion of 
human cathelicidin hCAP-18/LL-37
16. Given these studies 
and our results, ADSC cultured media may play a major 
role in balancing the expression of epidermal AMP.
However, there are some limitations to the effectiveness of 
ADSC cultured media. The concentration of ADSC cultured 
media depends on the general status of its donor, such as 
age, sex, and medical status. Therefore, it is difficult to 
maintain a standardized concentration and content. This 
limitation is similar to that of herbal medicine, but can be 
corrected to some degree by selecting standardized donors. 
Moreover, previous studies have produced inconsistent 
results with the components of cytokine in stem cell 
extracts, which showed only prostaglandins and not IL-10, 
TGF-β, or HGF
3-5. Therefore, an advanced and standar-
dized cytokine profile assay may be indispensible for 
analyzing the cytokines of stem cell extracts in further 
studies.
In summary, we confirm that ADSC cultured media 
improves visible AD lesions, TEWL, SC hydration, 
keratinocyte differentiation, AMPs, and inflammation in an 
oxazolone-induced murine model of AD. From these 
results, we conclude that topical application of ADSC 
cultured media improves AD lesions through a mechanism 
improving the epidermal permeability barrier, differen-
tiation, and epidermal AMP expression, as well as suppre-
ssing TH2 cells. This result indicates that ADSC cultured 
media may be useful in the treatment of AD. 
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